The Enterprise Value as of December 2025 (TTM) for Invex Therapeutics Ltd (IXC.AX) is 3.64M

According to Invex Therapeutics Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 3.64M. This represents a change of -1536.91% compared to the average of -253558.77 of the last 4 quarters.

Invex Therapeutics Ltd (IXC.AX) Historical Enterprise Value (quarterly & annually)

How has IXC.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Invex Therapeutics Ltd over the last ten years is 15.55M. The current 3.64M Enterprise Value has changed 2.24% with respect to the historical average. Over the past ten years (40 quarters), IXC.AX's Enterprise Value was at its highest in in the June 2020 quarter at 48.25M. The Enterprise Value was at its lowest in in the June 2019 quarter at -12170247.00.

Invex Therapeutics Ltd (IXC.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Invex Therapeutics Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Invex Therapeutics Ltd (IXC.AX) Average Enterprise Value

How has IXC.AX Enterprise Value performed in the past?

The current Enterprise Value of Invex Therapeutics Ltd (IXC.AX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Invex Therapeutics Ltd (IXC.AX) Enterprise Value vs. Peers

How is IXC.AX’s Enterprise Value compared to its peers?

Invex Therapeutics Ltd’s Enterprise Value is less than Bio-Gene Technology Limited (6.84M), less than Vectus Biosystems Limited (5.82M), less than Memphasys Limited (14.63M), greater than Percheron Therapeutics Limited (-2529928.00), greater than Intelicare Holdings Limited (0), less than Chimeric Therapeutics Limited (6.99M), less than Biotron Limited (4.05M), less than Acrux Limited (9.34M), less than Cann Group Limited (81.46M), less than Adherium Limited (10.78M),

Build a custom stock screener for Invex Therapeutics Ltd (IXC.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Invex Therapeutics Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Invex Therapeutics Ltd (IXC.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Invex Therapeutics Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.